These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4102056)

  • 1. Growth hormone, sorbitol, and diabetic capillary disease.
    Gabbay KH; Kinoshita JH
    Lancet; 1971 May; 1(7705):913. PubMed ID: 4102056
    [No Abstract]   [Full Text] [Related]  

  • 2. Growth hormone, sorbitol, and diabetic capillary disease.
    Beaumont P; Schofield PJ; Hollows FC; Wiows FC; Steinbeck AW; Williams JF
    Lancet; 1971 Mar; 1(7699):579-81. PubMed ID: 4100908
    [No Abstract]   [Full Text] [Related]  

  • 3. Growth hormone and diabetic angiopathy.
    Lundbaek K; Jensen VA; Olsen TS; Orskov H; Christensen NJ; Johansen K; Hansen AP; Osterby R
    Lancet; 1970 Aug; 2(7670):472. PubMed ID: 4195153
    [No Abstract]   [Full Text] [Related]  

  • 4. [Sorbitol route of glucose metabolism and complication of diabetes mellitus].
    Efimov AS; Skrobonskaia NA; Petakh NN
    Probl Endokrinol (Mosk); 1980; 26(3):86-90. PubMed ID: 6773043
    [No Abstract]   [Full Text] [Related]  

  • 5. [Risk factors for diabetic complications: Abnormality of polyol metabolism].
    Hotta N
    Nihon Rinsho; 2002 Oct; 60 Suppl 10():60-6. PubMed ID: 12430208
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clinical significance of erythrocyte sorbitol, sorbitol dehydrogenase and glyceraldehyde reductase in diabetic complications].
    Hosojima H
    Nihon Rinsho; 1990 Dec; 48 Suppl():426-31. PubMed ID: 2086917
    [No Abstract]   [Full Text] [Related]  

  • 7. [Possible role of growth hormone in vascular complications of diabetes].
    Canivet J
    Journ Annu Diabetol Hotel Dieu; 1978; ():217-25. PubMed ID: 651098
    [No Abstract]   [Full Text] [Related]  

  • 8. Accumulation of sorbitol in endothelial cells--a possible cause of diabetic microangiopathy.
    Koh MS; Misch KJ; Yuen CT; Rhodes EL
    Diabetes Res; 1986 May; 3(4):217-9. PubMed ID: 3742943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diabetes, diabetic angiopathy, and growth hormone.
    Lundbaek K; Christensen NJ; Jensen VA; Johansen K; Olsen TS; Hansen AP; Orskov H; Osterby R
    Lancet; 1970 Jul; 2(7664):131-3. PubMed ID: 4194508
    [No Abstract]   [Full Text] [Related]  

  • 10. [Erythrocyte sorbitol, sorbitol dehydrogenase (SDH), and glyceraldehyde reductase (GAR) in diabetes mellitus].
    Hosojima H
    Nihon Rinsho; 2002 Aug; 60 Suppl 8():486-91. PubMed ID: 12355795
    [No Abstract]   [Full Text] [Related]  

  • 11. [New theories of the pathogenesis of diabetic neuropathies].
    Lekishvili VP
    Klin Med (Mosk); 1974 Nov; 52(11):14-6. PubMed ID: 4373612
    [No Abstract]   [Full Text] [Related]  

  • 12. Glucose-dependent changes in aortic wall metabolism.
    JAMA; 1970 Mar; 211(13):2150. PubMed ID: 5467175
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diabetic macroangiopathy].
    Ledet T; Wogensen LD; Rasmussen LM
    Ugeskr Laeger; 2005 Jun; 167(23):2499-502. PubMed ID: 16008002
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of polyol pathway in pathogenesis of diabetic microangiopathy].
    Nakamura J
    Nihon Rinsho; 2005 Jun; 63 Suppl 6():52-61. PubMed ID: 15999685
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathobiochemistry of the late-onset diabetic syndrome].
    Wieland OH
    Ther Ggw; 1974 Sep; 113(9):1448-63. PubMed ID: 4280154
    [No Abstract]   [Full Text] [Related]  

  • 16. Glucose and diabetic vascular disease.
    Ruderman NB; Williamson JR; Brownlee M
    FASEB J; 1992 Aug; 6(11):2905-14. PubMed ID: 1644256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth hormone and diabetic angiopathy.
    Lundbaek K
    Acta Diabetol Lat; 1971 Sep; 8 Suppl 1():344-72. PubMed ID: 5146909
    [No Abstract]   [Full Text] [Related]  

  • 18. [Pathobiochemistry of the late-onset diabetic syndrome].
    Wieland OH
    Med Klin; 1974 Sep; 69(36):1417-23. PubMed ID: 4437430
    [No Abstract]   [Full Text] [Related]  

  • 19. Glucose-induced microvascular functional changes in nondiabetic rats are stereospecific and are prevented by an aldose reductase inhibitor.
    Williamson JR; Ostrow E; Eades D; Chang K; Allison W; Kilo C; Sherman WR
    J Clin Invest; 1990 Apr; 85(4):1167-72. PubMed ID: 2108189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Possibilities of preventing diabetic angiopathy (pathogenetic factors in angiopathy)].
    Tsvetanov L
    Vutr Boles; 1976; 15(2):81-6. PubMed ID: 779275
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.